PharmiWeb.com - Global Pharma News & Resources

Training - Events

29-Apr-2019 - 29-Apr-2019

41, Münchensteinerstrasse, Basel, Basel-Stadt, 4052, Switzerland

In an increasingly cost-conscious health care environment, pharma companies must make a thorough case for not only the clinical, but also the economic value of their products. These days, clinical efficacy alone is not enough; both clinical effectiveness and 'value for money' are essential to make sure the product reaches the patients for whom it is intended. Course Topics Introduction to Market Access Landscape: Who are the Stakeholders and what are ytheir perspectives Health Outcome Assessment types Pricing Country systems

100-110, Euston Road, London, Greater London, NW1 2AJ, United Kingdom

Indirect treatment comparisons (ITC) and mixed treatment comparisons (MTC), collectively referred to as Network Meta-Analysis (NMA), are increasingly used in health technology assessment. They are statistical techniques to synthesise available direct and indirect evidence to provide information on the comparative effectiveness and safety of a range of competing interventions. Network meta-analyses are often complex and challenging projects to specify and undertake and bring with them a range of planning considerations that are critical for a successful end product. These considerations include specifying the review question, identifying relevant studies, deciding how to assess the similarity of studies in a potential network and developing the statistical analysis plan and using the NMA…

41, Münchensteinerstrasse, Basel, Basel-Stadt, 4052, Switzerland

In modern global pharmaceutical companies it is becoming increasingly important for non-statisticians to understand the value and application of statistics in order to maximise the value of the data.This course is designed for professionals working in the pharmaceutical industry with no or little previous knowledge of Statistics as we start right at the beginning with the basics.It will be non-software focused, but rather understanding the basic statistical concepts, interpreting output and discussing how the knowledge can be applied and integrated efficiently into the job role.
14-May-2019 - 14-May-2019

York, York, YO10 5DD, United Kingdom

The Five Year Forward View in 2014 set out the challenges facing the NHS in England in the coming years, namely ensuring the ongoing delivery of high quality care for patients in the face of constrained funding and ever increasing demand. The same challenges exist in the rest of the UK and health care commissioners and providers are working out how to address these issues at national and local levels. The NHS needs to redesign the way in which services are provided and initiatives such as the New Models of Care Vanguard programme and Sustainability and Transformation Plans are in place to help with this. Many new service redesign initiatives are being piloted and rolled out across the UK. In making a case for service redesign, it is crucial that NHS providers and commissioners understan…

York, York, YO10 5DD, United Kingdom

Diagnostic test accuracy studies are receiving increasing attention, but are challenging to identify efficiently and reliably. As well as health care professionals seeking information on best evidence on test accuracy, there is also a growing requirement for systematic study identification to inform systematic reviews and technology assessments of diagnostic tests and techniques. The growing number of diagnostic test accuracy reviews is an important resource for the practice of evidence-based health care. This training day will provide an introduction to the key features of diagnostic test accuracy studies to provide insight into retrieval challenges. This will be followed by an overview of the research evidence on search approaches to identify diagnostic studies and the key current res…

41, Münchensteinerstrasse, Basel, Basel-Stadt, 4052, Switzerland

This course is designed for those working/interacting with the vendors to deliver your clinical trials. How do you ensure you manage them to optimise your clinical trial delivery? What is required for compliant vendor oversight? What could put you at risk of inspection findings? Do you require a governance system with your vendors? How should you implement this for your outsourcing model and how will it add value? What is the best approach to maintain healthy business relationships when outsourcing? How do you drive performance transparency through use of metrics?
19-Jun-2019 - 19-Jun-2019

11, The Rembrandt Hotel, Thurloe Place, London, Greater London, SW7 2RS, United Kingdom

This interactive one day course will provide an introduction to mindfulness and encourage new ways of thinking and working, as well as help you relate to stress and problems in a different way.

York, York, YO10 5DD, United Kingdom

Economic evaluations are increasingly used as tools to inform decision-makers about the cost-effectiveness of health technologies. Such evaluations are often undertaken during the late stages of the technology development (i.e. around the time of product launch or, in some cases, post-launch). However, there is an increasing need for the manufacturers of the technology to appraise the likely cost-effectiveness of the intervention before making decisions on price and indication, as well as to inform the development of clinical trials. The purposes of early economic modelling is to allow the user to determine the relative importance of different parameter inputs, in order to inform decisions on pricing, target populations and prioritisation of further research. This one-day training sessi…
03-Jul-2019 - 03-Jul-2019

York, York, YO10 5DD, United Kingdom

Cost-utility analysis is a requirement for NICE health technology appraisals and is being increasingly used in other contexts and countries. Health utilities, a crucial component of cost-utility analysis, capture the relative change in health-related quality of life resulting from a treatment. As such, health utility can be a key driver of the cost-effectiveness ratio. Obtaining health utility values that are suitable for your economic evaluation, however, may not always be straight forward. This one-day training course complements the early economic modelling course, discussing issues around different approaches to obtaining utility values. It introduces each approach in turn, giving an overview of the implementation, strengths, and limitations of each, across different contexts. Fu…